Describes the capabilities a FHIR client will use to implement the functionality of the MyPAIN application

Describes the required capabilities a FHIR server must support to be usable as the server for the MyPAIN application

Describes the capabilities a FHIR client will use to implement the functionality of the PainManager application

Describes the required capabilities a FHIR server must support to be usable as the server for the PainManager application

A questionnaire to use with the MyPAIN application for a patient to assess their pain levels, locations, and treatments for use in consultation with a clinician to determine further treatments.

Profile of observation used to characterize assessment responses from the MyPAIN questionnaire as observation resources available for provider review during a shared decision-making session using the PainManager application

Profile of observation used to characterize boolean-valued assessment responses from the MyPAIN questionnaire as observation resources available for provider review during a shared decision-making session using the PainManager application

Profile of observation used to characterize codeable assessment responses from the MyPAIN questionnaire as observation resources available for provider review during a shared decision-making session using the PainManager application

Profile of observation used to characterize text assessment responses from the MyPAIN questionnaire as observation resources available for provider review during a shared decision-making session using the PainManager application

Value set for Questionnaire Response Codes used in the MyPAIN Questionnaire

All naloxone medications

ValueSet containing all general screening tests in urine for drugs of abuse other than narcotics codes.

Value set for Opioid drugs

Value set for Pain Therapy and Strategy Observations used in MyPAIN and Pain Manager

Value set for Pain Types used in MyPAIN and Pain Manager

ValueSet containing all diagnosis and findings indicating drug abuse codes.

Value set for 3-item Likert scale questions used in MyPAIN and Pain Manager

This value set contains codes that represent medications which may be of potential therapeutic benefit in treating chronic pain. It does not include opiate and opioid class medications.

Pregnancy

Conditions associated with sleep-related breathing disorders.

This value set contains codes representing conditions related to anxiety.

Conditions that indicate chronic pain or are likely to cause chronic pain.

This value set contains concepts that represent a diagnosis of liver disease.

This value set contains concepts that represent major depression.

This value set contains concepts that represent kidney failure.

This value set contains concepts that represent a diagnosis of chronic liver disease.

This value set contains concepts related to the diagnosis of pregnancy.

Pain interference valueset answers.

Survey agreement answers valueset.

Past pain levels valueset.

Current pain level valueset.

All benzodiazepine clinical drugs

Individual tests and panels of tests of urine for drugs of misuse

The empty value set, used to indicate that a reusable concept defined in the concepts library has no meaning in a given configuration

Value set for All Questionnaire Codes used in the MyPAIN Questionnaire

Value set for All Questionnaire Response Codes used in the MyPAIN Questionnaire

Value set for Questionnaire Codes used in the MyPAIN Questionnaire

Code system for questions from questionnaire used in MyPAIN and Pain Manager

Code system for responses from questionnaire used in MyPAIN and Pain Manager

Code system for Pain Therapy and Strategy Observations used in MyPAIN and Pain Manager

This Code System Supplement defines conversion factors for calculating Morphine Milligram Equivalence (MME) using conversion factors used by default for the CDS4CPM Project. The supplement defines conversions factors for ingredients in one of 3 ways: 1, as a direct conversion factor for the ingredient, 2, as a dose-form-specific conversion factor for the ingredient, and 3, as a dose-ranged conversion factor for the ingredient. See the descriptions for each property for information on how the values are represented for the different conversion factors. For a given ingredient, only one type of property will be present, and the properties will enable a unique conversion factor to be determined if the input is within the expected range. If the input is outside the expected range, implementations should indicate a conversion factor could not be determined from the supplied information. All conversion factors supplied in this supplement are in ‘mg/d’.